Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods.
Reeves GM, Keeton C, Correll CU, Johnson JL, Hamer RM, Sikich L, Hazzard L, Alderman C, Scheer A, Mabe M, Kapoor S, Sheridan E, Borner I, Bussell K, Pirmohamed S, Bethea TC, Chekuri R, Gottfried R, Reinblatt SP, Santana E, Riddle MA. Reeves GM, et al. Among authors: chekuri r. Child Adolesc Psychiatry Ment Health. 2013 Aug 15;7(1):31. doi: 10.1186/1753-2000-7-31. Child Adolesc Psychiatry Ment Health. 2013. PMID: 23947389 Free PMC article.
Frequency, characteristics and management of adolescent inpatient aggression.
Baeza I, Correll CU, Saito E, Amanbekova D, Ramani M, Kapoor S, Chekuri R, De Hert M, Carbon M. Baeza I, et al. Among authors: chekuri r. J Child Adolesc Psychopharmacol. 2013 May;23(4):271-81. doi: 10.1089/cap.2012.0116. Epub 2013 May 6. J Child Adolesc Psychopharmacol. 2013. PMID: 23647136 Free PMC article.
Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics.
Stentebjerg-Olesen M, Jeppesen P, Pagsberg AK, Fink-Jensen A, Kapoor S, Chekuri R, Carbon M, Al-Jadiri A, Kishimoto T, Kane JM, Correll CU. Stentebjerg-Olesen M, et al. Among authors: chekuri r. J Child Adolesc Psychopharmacol. 2013 Dec;23(10):665-75. doi: 10.1089/cap.2013.0007. Epub 2013 Nov 22. J Child Adolesc Psychopharmacol. 2013. PMID: 24266529 Free PMC article.
Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.
Penzner JB, Dudas M, Saito E, Olshanskiy V, Parikh UH, Kapoor S, Chekuri R, Gadaleta D, Avedon J, Sheridan EM, Randell J, Malhotra AK, Kane JM, Correll CU. Penzner JB, et al. Among authors: chekuri r. J Child Adolesc Psychopharmacol. 2009 Oct;19(5):563-73. doi: 10.1089/cap.2009.0051. J Child Adolesc Psychopharmacol. 2009. PMID: 19877981 Free PMC article. Clinical Trial.
Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice.
Kishi T, Fujita K, Furukawa O, Suzuki T, Moriwaki M, Nitta M, Hattori M, Tsunoka T, Chekuri R, Kane JM, Correll CU, Iwata N. Kishi T, et al. Among authors: chekuri r. Asian J Psychiatr. 2013 Jun;6(3):200-7. doi: 10.1016/j.ajp.2012.10.007. Epub 2012 Nov 30. Asian J Psychiatr. 2013. PMID: 23642976 Clinical Trial.
12 results